FOXF1-deficient endothelial cells were associated with accelerated lung fibrosis and inflammation, and lung delivery of FOXF1 cDNA via nanoparticles attenuated lung fibrosis development in mice treated with bleomycin, showing the potential of this finding as a treatment strategy in IPF [44]. The gene discussed is FOXF1; the disease is pulmonary fibrosis.